Breaking News Instant updates and real-time market news.

NAK

Northern Dynasty

$0.37 /

-0.4401 (-54.33%)

14:10
11/25/20
11/25
14:10
11/25/20
14:10

Northern Dynasty announces denial of Pebble's application for permits

Northern Dynasty Minerals has announced that its 100%-owned, U.S.-based subsidiary Pebble Limited Partnership received formal notification from the U.S. Army Corps of Engineers that its application for permits under the Clean Water Act and other federal statutes has been denied. The lead federal regulator found Pebble's 'compensatory mitigation plan' as submitted earlier this month to be "non-compliant," and that the project is "not in the public interest." Northern Dynasty called the decision "politically motivated" and said it is "fundamentally unsupported" by the administrative record as developed by the USACE through the Environmental Impact Statement process for the Pebble Project. Northern Dynasty confirmed that the Pebble Partnership will appeal the USACE permitting decision within the 60-day window provided for it to do so.

  • 30

    Nov

  • 11

    May

NAK Northern Dynasty
$0.37 /

-0.4401 (-54.33%)

11/09/20 TD Securities
Northern Dynasty price target lowered to C$1.15 from C$1.70 at TD Securities
07/28/20 BMO Capital
Northern Dynasty price target raised to C$3.50 from C$1.50 at BMO Capital
06/29/20 TD Securities
Northern Dynasty price target raised to C$2.25 from C$1.30 at TD Securities
05/14/20 TD Securities
Northern Dynasty price target raised to C$1.30 from C$0.75 at TD Securities

TODAY'S FREE FLY STORIES

Earnings
ASML sees Q1 net sales EUR 3.9B-EUR 4.1B, gross margin 50%-51%  07:07
01/20/21
01/20
07:07
01/20/21
07:07
ASML

ASML

$549.18 /

+21.25 (+4.03%)

 
ShowHide Related Items >><<
ASML ASML
$549.18 /

+21.25 (+4.03%)

01/19/21 Barclays
ASML price target raised to EUR 525 from EUR 475 at Barclays
01/15/21 JPMorgan
ASML price target raised to EUR 437 from EUR 408 at JPMorgan
01/14/21 Barclays
ASML price target raised to EUR 475 from EUR 425 at Barclays
01/13/21 UBS
ASML price target raised to EUR 430 from EUR 395 at UBS
ASML ASML
$549.18 /

+21.25 (+4.03%)

ASML ASML
$549.18 /

+21.25 (+4.03%)

Hot Stocks
Evelo Biosciences reports confirmatory data from Phase 1b trial of EDP1815 » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
EVLO

Evelo Biosciences

$15.49 /

+1.23 (+8.63%)

Evelo Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$15.49 /

+1.23 (+8.63%)

EVLO Evelo Biosciences
$15.49 /

+1.23 (+8.63%)

12/30/20 JMP Securities
Evelo shares undervalued into atopic dermatitis data, says JMP Securities
12/23/20 JMP Securities
Evelo Biosciences initiated with an Outperform at JMP Securities
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
EVLO Evelo Biosciences
$15.49 /

+1.23 (+8.63%)

  • 25
    Jun
Initiation
J.M. Smucker initiated with a Neutral at Citi » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
SJM

J.M. Smucker

$115.65 /

+1.545 (+1.35%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

01/19/21 JPMorgan
J.M. Smucker price target lowered to $115 from $122 at JPMorgan
09/16/20 Morgan Stanley
J.M. Smucker price target lowered to $106 from $114 at Morgan Stanley
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Deutsche Bank
J.M. Smucker price target raised to $127 from $121 at Deutsche Bank
SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

Earnings
ASML reports Q4 EPS EUR 3.23 vs. EUR 2.54 last quarter » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
ASML

ASML

$549.18 /

+21.25 (+4.03%)

Reports Q4 net sales EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$549.18 /

+21.25 (+4.03%)

01/19/21 Barclays
ASML price target raised to EUR 525 from EUR 475 at Barclays
01/15/21 JPMorgan
ASML price target raised to EUR 437 from EUR 408 at JPMorgan
01/14/21 Barclays
ASML price target raised to EUR 475 from EUR 425 at Barclays
01/13/21 UBS
ASML price target raised to EUR 430 from EUR 395 at UBS
ASML ASML
$549.18 /

+21.25 (+4.03%)

ASML ASML
$549.18 /

+21.25 (+4.03%)

Hot Stocks
Ocuphire Pharma reports results from ORION-1 Phase 2 clinical trial » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
OCUP

Ocuphire Pharma

$7.81 /

+0.75 (+10.62%)

Ocuphire Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$7.81 /

+0.75 (+10.62%)

OCUP Ocuphire Pharma
$7.81 /

+0.75 (+10.62%)

11/19/20 Cantor Fitzgerald
Ocuphire Pharma initiated with an Overweight at Cantor Fitzgerald
Initiation
Energias de Portugal resumed with an Overweight at Morgan Stanley » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
EDPFY

Energias de Portugal

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDPFY Energias de Portugal
$0.00 /

+ (+0.00%)

09/21/20 RBC Capital
Energias de Portugal upgraded to Sector Perform at RBC Capital
09/16/20 Credit Suisse
Energias de Portugal price target raised to EUR 5 at Credit Suisse
08/28/20 JPMorgan
Energias de Portugal price target raised to EUR 4.65 from EUR 4.50 at JPMorgan
08/23/20 Goldman Sachs
Energias de Portugal upgraded to Conviction Buy from Buy at Goldman Sachs
Hot Stocks
Applied DNA Sciences promotes Judith Murrah to the role of COO » 07:04
01/20/21
01/20
07:04
01/20/21
07:04
APDN

Applied DNA Sciences

$11.17 /

+0.1901 (+1.73%)

Applied DNA Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APDN Applied DNA Sciences
$11.17 /

+0.1901 (+1.73%)

APDN Applied DNA Sciences
$11.17 /

+0.1901 (+1.73%)

01/14/21 H.C. Wainwright
Applied DNA Sciences price target lowered to $14 from $18 at H.C. Wainwright
01/11/21 H.C. Wainwright
Applied DNA Sciences price target raised to $18 from $12 at H.C. Wainwright
12/30/20 H.C. Wainwright
H.C. Wainwright keeps $12 target on Applied DNA Sciences after partnership
12/18/20 H.C. Wainwright
Applied DNA Sciences price target lowered to $12 from $20 at H.C. Wainwright
APDN Applied DNA Sciences
$11.17 /

+0.1901 (+1.73%)

Hot Stocks
Main Street reports Q4 private loan activity » 07:04
01/20/21
01/20
07:04
01/20/21
07:04
MAIN

Main Street

$32.63 /

+0.31 (+0.96%)

Main Street reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAIN Main Street
$32.63 /

+0.31 (+0.96%)

MAIN Main Street
$32.63 /

+0.31 (+0.96%)

08/12/20 Truist
Main Street price target raised to $33 from $28 at Truist
04/15/20 National Securities
Main Street downgraded to Neutral from Buy at National Securities
03/17/20 National Securities
Main Street upgraded to Buy from Neutral at National Securities
MAIN Main Street
$32.63 /

+0.31 (+0.96%)

Earnings
Murphy USA reports preliminary 2020 EPS $13.08, consensus $13.18 » 07:04
01/20/21
01/20
07:04
01/20/21
07:04
MUSA

Murphy USA

$124.84 /

+0.37 (+0.30%)

"As we exit 2020, we…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/01/20
Fly Intel: Top five analyst initiations
12/01/20 Goldman Sachs
Murphy USA initiated with a Sell at Goldman Sachs
11/20/20 Jefferies
Murphy USA assumed with a Hold at Jefferies
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

Earnings
Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
PG

Procter & Gamble

$133.56 /

-1.275 (-0.95%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

01/19/21 Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
01/13/21 Deutsche Bank
Procter & Gamble price target raised to $159 from $156 at Deutsche Bank
01/06/21 Evercore ISI
PepsiCo downgraded to In Line to reflect macro view at Evercore ISI
12/07/20 Wells Fargo
Colgate-Palmolive initiated with an Underweight at Wells Fargo
PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

Recommendations
Citi adds PPG to US Focus List, removes FMC » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
PPG

PPG

$145.00 /

-3 (-2.03%)

, FMC

FMC Corporation

$116.60 /

-3.43 (-2.86%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPG PPG
$145.00 /

-3 (-2.03%)

FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

PPG PPG
$145.00 /

-3 (-2.03%)

01/14/21 Berenberg
PPG upgraded to Buy with $165 price target at Berenberg
01/14/21 Berenberg
PPG upgraded to Buy from Hold at Berenberg
12/01/20 Deutsche Bank
PPG price target raised to $165 from $155 at Deutsche Bank
12/01/20 Barclays
PPG price target raised to $155 from $151 at Barclays
FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

06:44 Today Citi
FMC Corporation price target lowered to $138 from $141 at Citi
11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
FMC Corporation initiated with a Market Perform at Bernstein
11/18/20 BMO Capital
FMC Corporation price target raised to $124 from $120 at BMO Capital
PPG PPG
$145.00 /

-3 (-2.03%)

FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

PPG PPG
$145.00 /

-3 (-2.03%)

FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

PPG PPG
$145.00 /

-3 (-2.03%)

Hot Stocks
Imara appoints Kenneth Atttie as Chief Medical Officer » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
IMRA

Imara

$14.08 /

+0.38 (+2.77%)

Imara announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMRA Imara
$14.08 /

+0.38 (+2.77%)

IMRA Imara
$14.08 /

+0.38 (+2.77%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
IMRA Imara
$14.08 /

+0.38 (+2.77%)

  • 12
    Mar
IMRA Imara
$14.08 /

+0.38 (+2.77%)

Earnings
Murphy USA reports preliminary Q4 EPS $2.16, consensus $1.94 » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
MUSA

Murphy USA

$124.84 /

+0.37 (+0.30%)

Net income for the fourth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/01/20
Fly Intel: Top five analyst initiations
12/01/20 Goldman Sachs
Murphy USA initiated with a Sell at Goldman Sachs
11/20/20 Jefferies
Murphy USA assumed with a Hold at Jefferies
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

Hot Stocks
Fulton Financial sees 2021 net interest income $620M-$640M » 07:02
01/20/21
01/20
07:02
01/20/21
07:02
FULT

Fulton Financial

$14.79 /

+0.28 (+1.93%)

Sees 2021 provision for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

06/17/20 Raymond James
Fulton Financial upgraded to Outperform from Market Perform at Raymond James
06/01/20 Stephens
Fulton Financial initiated with an Equal Weight at Stephens
FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

Initiation
Aalberts initiated with an Overweight at Morgan Stanley » 07:02
01/20/21
01/20
07:02
01/20/21
07:02
AALBF

Aalberts

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AALBF Aalberts
$0.00 /

+ (+0.00%)

07/28/20 Kepler Cheuvreux
Aalberts upgraded to Buy from Hold at Kepler Cheuvreux
07/24/20 ABN Amro
Aalberts upgraded to Buy from Hold at ABN Amro
Recommendations
Arcus Biosciences price target raised to $51 from $32 at Citi » 07:01
01/20/21
01/20
07:01
01/20/21
07:01
RCUS

Arcus Biosciences

$36.74 /

-0.26 (-0.70%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCUS Arcus Biosciences
$36.74 /

-0.26 (-0.70%)

RCUS Arcus Biosciences
$36.74 /

-0.26 (-0.70%)

01/19/21 Wedbush
Arcus Biosciences price target raised to $55 from $48 at Wedbush
01/19/21 Truist
Arcus Biosciences price target raised to $70 from $45 at Truist
01/13/21 Cantor Fitzgerald
Arcus Biosciences price target raised to $62 from $39 at Cantor Fitzgerald
12/22/20 Mizuho
Autolus, Arcus among top 2021 oncology picks at Mizuho
RCUS Arcus Biosciences
$36.74 /

-0.26 (-0.70%)

  • 29
    May
Hot Stocks
Bristol-Myers: FDA accepts for Priority Review sBLA for Opdivo combination » 07:01
01/20/21
01/20
07:01
01/20/21
07:01
BMY

Bristol-Myers

$66.73 /

+0.16 (+0.24%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$66.73 /

+0.16 (+0.24%)

BMY Bristol-Myers
$66.73 /

+0.16 (+0.24%)

06:51 Today Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
12/15/20 Goldman Sachs
Bristol-Myers upgraded to Conviction Buy from Buy at Goldman Sachs
12/09/20 Mizuho
Pentwater seeks to replace Bristol-Myers Squibb CVR trustee, says Mizuho
11/30/20 Citi
Bristol-Myers price target raised to $77 from $73 at Citi
BMY Bristol-Myers
$66.73 /

+0.16 (+0.24%)

BMY Bristol-Myers
$66.73 /

+0.16 (+0.24%)

BMY Bristol-Myers
$66.73 /

+0.16 (+0.24%)

BMY Bristol-Myers
$66.73 /

+0.16 (+0.24%)

General news
FX Update: The dollar traded softer for a third day » 07:00
01/20/21
01/20
07:00
01/20/21
07:00

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Sulzer initiated with an Equal Weight at Morgan Stanley » 06:59
01/20/21
01/20
06:59
01/20/21
06:59
SULZF

Sulzer

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SULZF Sulzer
$0.00 /

+ (+0.00%)

04/28/20 UBS
Sulzer price target lowered to CHF 107 from CHF 118 at UBS
04/15/20 UBS
Sulzer price target lowered to CHF 118 from CHF 130 at UBS
Initiation
Stellantis initiated with an Overweight at JPMorgan » 06:59
01/20/21
01/20
06:59
01/20/21
06:59
STLA

Stellantis

$16.91 /

+1.68 (+11.03%)

JPMorgan analyst Jose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Ryanair downgraded to Neutral from Overweight at JPMorgan » 06:57
01/20/21
01/20
06:57
01/20/21
06:57
RYAAY

Ryanair

$106.21 /

-2.04 (-1.88%)

JPMorgan analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYAAY Ryanair
$106.21 /

-2.04 (-1.88%)

RYAAY Ryanair
$106.21 /

-2.04 (-1.88%)

12/17/20 Morgan Stanley
Ryanair price target raised to EUR 18 from EUR 15.60 at Morgan Stanley
12/16/20 Raymond James
Ryanair price target raised to $125 from $100 at Raymond James
12/07/20 UBS
Ryanair price target raised to EUR 15.65 from EUR 14.70 at UBS
12/07/20 Wolfe Research
Ryanair initiated with a Peer Perform at Wolfe Research
RYAAY Ryanair
$106.21 /

-2.04 (-1.88%)

Hot Stocks
Geo Group's contract for Moshannon Valley facility not renewed » 06:57
01/20/21
01/20
06:57
01/20/21
06:57
GEO

Geo Group

$9.08 /

-0.155 (-1.68%)

The GEO Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GEO Geo Group
$9.08 /

-0.155 (-1.68%)

GEO Geo Group
$9.08 /

-0.155 (-1.68%)

06/29/20 Noble Capital
Geo Group initiated with an Outperform at Noble Capital
GEO Geo Group
$9.08 /

-0.155 (-1.68%)

GEO Geo Group
$9.08 /

-0.155 (-1.68%)

Recommendations
Citi opens 'Positive Catalyst Watch' on Novo Nordisk » 06:55
01/20/21
01/20
06:55
01/20/21
06:55
NVO

Novo Nordisk

$73.01 /

+0.99 (+1.37%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

06:34 Today Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
05:28 Today Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
01/15/21 Deutsche Bank
Novo Nordisk initiated with a Buy at Deutsche Bank
11/16/20 Piper Sandler
Piper says 'underwhelming' data from Novo Nordisk a 'big win' for Intercept
NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

Conference/Events
Calliditas Therapeutics to host virtual research and development day » 06:55
01/20/21
01/20
06:55
01/20/21
06:55
CALT

Calliditas Therapeutics

$31.90 /

+1.35 (+4.42%)

Research and Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALT Calliditas Therapeutics
$31.90 /

+1.35 (+4.42%)

CALT Calliditas Therapeutics
$31.90 /

+1.35 (+4.42%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
  • 05
    Jun
Upgrade
Netflix upgraded to Buy from Neutral at UBS on strong global sub growth » 06:54
01/20/21
01/20
06:54
01/20/21
06:54
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

06:53 Today
UBS upgraded to Buy at UBS on strong global sub growth, cash flow comments
05:51 Today Wells Fargo
Netflix upgraded to Overweight with $700 price target at Wells Fargo
05:11 Today Wells Fargo
Netflix upgraded to Overweight from Equal Weight at Wells Fargo
05:01 Today Piper Sandler
Netflix price target raised to $652 from $643 at Piper Sandler
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.